Skip to main content

Antipodean Advisors LLC

SEC CIK
0001512566
Latest filing
Nov 14, 2023

Holdings in Q4 2022

Holdings as of Dec 31, 2022, filed Feb 13, 2023. Long positions only; changes compare share counts with Q3 2022.

Institution overview
Positions
8
+1 vs. Q3 2022
Portfolio value
$29.9M
−$9.13M (−23.4%) vs. Q3 2022
Filed
Feb 13, 2023
SEC
Holdings of Antipodean Advisors LLC in Q4 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
SESea LtdSPONSORD ADS350,000$18.2M60.8%00.0%UnchangedHistory
GLDSPDR Gold TrustETF35,000$5.94M19.8%+35,000NewHistory
ATRAAtara Biotherapeutics, Inc.COM1,000,000$3.28M11.0%00.0%UnchangedHistory
CMAXCareMax, Inc.COM CL A425,000$1.55M5.2%00.0%UnchangedHistory
CDLXCardlytics, Inc.COM75,000$433.5K1.4%−465,400−86.1%ReducedHistory
VanEck ETF Trust92189F106GOLD MINERS ETF10,000$286.6K1.0%00.0%Unchanged–
UPSTUpstart Holdings, Inc.COM10,000$132.2K0.4%+10,000NewHistory
CVNACarvana Co.CL A25,000$118.5K0.4%−330,000−93.0%ReducedHistory

Sold out since Q3 2022 (1)

Positions held at the end of Q3 2022 that are gone from this filing.

Positions of Antipodean Advisors LLC sold out since Q3 2022
SecurityClassShares in Q3 2022Value in Q3 2022% of portfolio in Q3 2022History
VanEck Vectors ETF Tr92189F403RUSSIA ETF25,000$141.0K0.4%–